Cytokinetics

Cytokinetics is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative treatments aimed at improving muscle function in patients with debilitating diseases. The company focuses on creating first-in-class muscle activators and next-in-class muscle inhibitors to address conditions characterized by reduced muscle performance, such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. Utilizing small molecules specifically designed to enhance muscle function and contractility, Cytokinetics aims to advance investigational medicines that have the potential to improve health outcomes for individuals suffering from severe cardiovascular and neuromuscular disorders.

Robert Blum

President and CEO

3 past transactions

Imbria Pharmaceuticals

Series B in 2025
Imbria Pharmaceuticals, Inc. is a clinical-stage pharmaceuticals company based in Boston, Massachusetts, founded in 2018. The company specializes in developing innovative therapies aimed at addressing cardiometabolic disorders by enhancing or restoring cellular energy production. Imbria's research focuses on the mechanisms underlying these conditions, particularly in areas such as non-obstructive hypertrophic cardiomyopathy, stable angina, and heart failure with preserved ejection fraction. By translating scientific insights into practical treatments, Imbria Pharmaceuticals aims to meet significant unmet medical needs and improve the lives of patients affected by these life-altering disorders. Through its commitment to understanding cellular metabolism and mitochondrial function, the company works to advance healthcare solutions in the cardiometabolic space.

WomenHeart

Grant in 2023
WomenHeart is a non-profit organization serving American women living with or at risk for heart disease.

The Mended Hearts

Grant in 2023
The Mended Hearts Foundation provides support, education, and advocacy for heart disease patients. They provide a patient visiting program, education, support group meetings, and online communities. Their peer support groups help patients and their families understand that there can be a rich, rewarding life after a heart disease diagnosis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.